develop market life scienc
tool integr system analyz nucleic
acid creat develop market
life scienc tool integr system
requir disclosur end report
consum quiet need novaseq placement
reiter buy up pt
view current cl king meet event calendar coverag univers
crush estim provid guidanc despit tough
comp suggest better-than-expect growth back half
year high throughput consum number suggest potenti
growth novaseq placement thesi compani
five year unobstruct growth production-scal sequenc
investor underappreci abil scale sb chemistri think
novaseq shore weak near term reiter buy rate
rais price target
argument near term stock fairli depend novaseq
demand interestingli prove
placement might import mani investor expect
clear us novaseq consum pull-through suggest robust
three- five-year high throughput platform re-fleet obtain
quarter
novaseq impli placement track us consum blew
sequenti
consum compani didnt mention new high throughput
prepar remark confirm rate new high throughput
win remain slightli one-quart total placement
opinion drive new high throughput custom custom
consum util rang would repres upsid estim
nextseq benchtop four-year-old nextseq instrument continu
domin mid-throughput rang compani massiv
year-over-year growth consum manag call non-
invas prenat test nipt demand cancer panel word
clinic demand increas benchtop win remain steadi although
competit area competit fail match miseq
accuraci throughput reliabl
geographi growth balanc growth emea asia-
pacif america dollar rebound
somewhat quarter compani grew revenu period
fx contribut custom china made
stock order anticip tariff there notabl gap
perform local sequenc instrument compani
dont anticip major reduct sequenc
report revenu vs
beat our/th street respect estim
non-gaap ep beat our/street expect
all-around guidanc expect revenu
approxim adjust ep rang
ep rang previous expect
revenu adjust ep
rang ep rang
model increas respect revenu estim
also
rais adjust ep forecast
respect
valuat revis price target base price-to-earnings multipl
new ep estim although stock current
trade premium stock diagnost space believ
three five year unobstruct growth multibillion-dollar
address market multipl high end histor
trade rang howev visibl growth barrier entri never
higher
risk achiev price target
increas competit space
inabl protect proprietari technolog
adopt speed novaseq
decreas govern spend
chang fda rule
new york citi see list compani confirm regist click
page
